ClinConnect ClinConnect Logo
Search / Trial NCT03024658

Effect of Positive End Expiratory Pressure at the Time of Induction in Morbidly Obese Patients

Launched by SRI AUROBINDO INSTITUTE OF MEDICAL SCIENCES · Jan 14, 2017

Trial Information

Current as of August 11, 2025

Completed

Keywords

Pulmonary Artery Systolic Pressure Positive End Expiratory Pressure Morbidly Obese Laparoscopic Bariatric Surgery

ClinConnect Summary

This prospective study was conducted in the Department Of Anaesthesiology\& Critical Care, Sri Aurobindo Institute of Medical Sciences \& P.G. Institute and Mohak Hospitals, Indore, over a period of one year. Seventy morbidly obese patients, ASA grade II or III, aged 20-65 years with BMI \> 40kg/m2, scheduled for elective laparoscopic bariatric surgery were selected and a written informed consent was obtained. All the recruited patients underwent 2D-trans-thoracic echocardiography and PASP was recorded. Echocardiography was performed by same cardiologist as this measurement is operator depe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Patients recruited were
  • Anesthesia society of Anesthesiologist (ASA) physical status l, II or III,
  • Aged 20-65 years
  • BMI \> 40kg/m2
  • scheduled for elective laparoscopic bariatric surgery
  • Exclusion Criteria:
  • Patients who denied consent
  • Did not fulfill the inclusion criteria,
  • patients undergoing Emergency and/or open surgery
  • Patients requiring more than 2 attempts for intubation

About Sri Aurobindo Institute Of Medical Sciences

Sri Aurobindo Institute of Medical Sciences (SAIMS) is a premier healthcare institution dedicated to advancing medical research and clinical trials. With a strong commitment to improving patient care and outcomes, SAIMS integrates cutting-edge technology and innovative methodologies in its research initiatives. The institute fosters collaboration among healthcare professionals, researchers, and academic institutions, ensuring rigorous adherence to ethical standards and regulatory guidelines. By prioritizing patient safety and scientific integrity, SAIMS aims to contribute significantly to the development of novel therapeutic interventions and enhance the overall landscape of medical science.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials